Cargando…

Current status of achieving blood pressure target and its clinical correlates in Japanese type 2 diabetes (JDDM45)

AIMS/INTRODUCTION: To investigate the current status of achieved blood pressure levels in association with the number of antihypertensive drug classes as of 2013, and to explore the clinical correlates with achievement of target blood pressure in a large‐scale cohort of Japanese individuals with typ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yokoyama, Hiroki, Araki, Shin‐ichi, Kawai, Koichi, Hirao, Koichi, Kurihara, Yoshio, Seino, Hiroaki, Takamura, Hiroshi, Sugimoto, Hidekatsu, Okada, Akira, Maegawa, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934250/ https://www.ncbi.nlm.nih.gov/pubmed/28731289 http://dx.doi.org/10.1111/jdi.12714

Ejemplares similares

Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40)
por: Yokoyama, Hiroki, et al.
Publicado: (2016)

Declining trends of diabetic nephropathy, retinopathy and neuropathy with improving diabetes care indicators in Japanese patients with type 2 and type 1 diabetes (JDDM 46)
por: Yokoyama, Hiroki, et al.
Publicado: (2018)

Time and Costs of Insulin Treatment in the Care of Newly Registered Type 2 Diabetes Patients in Diabetes Clinics Across Japan (JDDM 22)
por: Oishi, Mariko, et al.
Publicado: (2011)

Family Support for Medical Nutritional Therapy and Dietary Intake among Japanese with Type 2 Diabetes (JDDM 56)
por: Horikawa, Chika, et al.
Publicado: (2020)

The renoprotective effect of once‐weekly GLP‐1 receptor agonist dulaglutide on progression of nephropathy in Japanese patients with type 2 diabetes and moderate to severe chronic kidney disease (JDDM67)
por: Tsuchida, Ken‐ichi, et al.
Publicado: (2022)

Combined Effects of Energy Intake and Physical Activity on Obesity in Japanese Patients with Type 2 Diabetes (JDDM 50): A Cross-Sectional Study
por: Hatta, Mariko, et al.
Publicado: (2019)

Liraglutide Versus Sitagliptin in a 24-week, Multicenter, Open-label, Randomized, Parallel-group Study in Japanese Type 2 Diabetes Mellitus Patients Responding Inadequately to a Sulfonylurea and/or One or Two Other Oral Antidiabetic Drugs (JDDM 33)
por: Yokoyama, Hiroki, et al.
Publicado: (2014)

Current status of oral antidiabetic drug prescribing patterns based on the body mass index for Japanese type 2 diabetes mellitus patients and yearly changes in diabetologists' prescribing patterns from 2002 to 2019 (JDDM61)
por: Yagi, Noriharu, et al.
Publicado: (2021)

Trends in glycemic control in patients with insulin therapy compared with non-insulin or no drugs in type 2 diabetes in Japan: a long-term view of real-world treatment between 2002 and 2018 (JDDM 66)
por: Yokoyama, Hiroki, et al.
Publicado: (2022)

Association between Obesity and Intake of Different Food Groups among Japanese with Type 2 Diabetes Mellitus—Japan Diabetes Clinical Data Management Study (JDDM68)
por: Hatta, Mariko, et al.
Publicado: (2022)

Comparison of baseline characteristics and clinical course in Japanese patients with type 2 diabetes among whom different types of oral hypoglycemic agents were chosen by diabetes specialists as initial monotherapy (JDDM 42)
por: Fujihara, Kazuya, et al.
Publicado: (2017)

Relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetic patients (JDDM38)
por: Kanatsuka, Azuma, et al.
Publicado: (2015)

Comparing Associations of Dietary Energy Density and Energy Intake, Macronutrients with Obesity in Patients with Type 2 Diabetes (JDDM 63)
por: Takeda, Yasunaga, et al.
Publicado: (2021)

Changes in prescription patterns and doses of oral antidiabetic drugs in Japanese patients with type 2 diabetes (JDDM70)
por: Shirabe, Shinichiro, et al.
Publicado: (2022)

Combination of disease duration‐to‐age at diagnosis and hemoglobin A1c‐to‐serum C‐peptide reactivity ratios predicts patient response to glucose‐lowering medication in type 2 diabetes: A retrospective cohort study across Japan (JDDM59)
por: Kanatsuka, Azuma, et al.
Publicado: (2021)

Evaluation of insulin regimens as an effective option for glycemic control in patients with type 2 diabetes: A propensity score‐matched cohort study across Japan (JDDM31)
por: Kanatsuka, Azuma, et al.
Publicado: (2014)

Clinical inertia in patients with type 2 diabetes treated with oral antidiabetic drugs: Results from a Japanese cohort study (JDDM53)
por: Maegawa, Hiroshi, et al.
Publicado: (2020)

Machine Learning Approach to Decision Making for Insulin Initiation in Japanese Patients With Type 2 Diabetes (JDDM 58): Model Development and Validation Study
por: Fujihara, Kazuya, et al.
Publicado: (2021)

Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002–2011 in Japan (JDDM32)
por: Oishi, Mariko, et al.
Publicado: (2013)

Higher Iron Intake Is Independently Associated with Obesity in Younger Japanese Type-2 Diabetes Mellitus Patients
por: Ferreira, Efrem d’Ávila, et al.
Publicado: (2022)

Fasting Insulin Levels and Metabolic Risk Factors in Type 2 Diabetic Patients at the First Visit in Japan: A 10-year, nationwide, observational study (JDDM 28)
por: Matsuba, Ikuro, et al.
Publicado: (2012)

Glucagon-Like Peptide-1 Receptor Agonist Utilization in Type 2 Diabetes in Japan: A Retrospective Database Analysis (JDDM 57)
por: Ishigaki, Yasushi, et al.
Publicado: (2020)

Clinical inertia in basal insulin-treated patients with type 2 diabetes – Results from a retrospective database study in Japan (JDDM 43)
por: Satoh, Jo, et al.
Publicado: (2018)

Factors associated with diabetic polyneuropathy‐related sensory symptoms and signs in patients with polyneuropathy: A cross‐sectional Japanese study (JDDM 52) using a non‐linear model
por: Yokoyama, Hiroki, et al.
Publicado: (2019)

Association between single nucleotide polymorphisms within genes encoding sirtuin families and diabetic nephropathy in Japanese subjects with type 2 diabetes
por: Maeda, Shiro, et al.
Publicado: (2011)

The Influence of a Single Nucleotide Polymorphism within CNDP1 on Susceptibility to Diabetic Nephropathy in Japanese Women with Type 2 Diabetes
por: Kurashige, Mahiro, et al.
Publicado: (2013)

Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014
por: Kume, Shinji, et al.
Publicado: (2019)

Oral glucose‐stimulated serum C‐peptide predicts successful switching from insulin therapy to liraglutide monotherapy in Japanese patients with type 2 diabetes and renal impairment
por: Araki, Hisazumi, et al.
Publicado: (2013)

Association Between Urinary Type IV Collagen Level and Deterioration of Renal Function in Type 2 Diabetic Patients Without Overt Proteinuria
por: Araki, Shin-ichi, et al.
Publicado: (2010)

COVID-19 associated pulmonary aspergillosis: a nationwide survey by the Japanese Respiratory Society
por: Takazono, Takahiro, et al.
Publicado: (2021)

Arterial stiffness and renal impairment in non‐proteinuric type 2 diabetic patients
por: Nakao, Keiko, et al.
Publicado: (2011)

Impact of obesity on annual medical expenditures and diabetes care in Japanese patients with type 2 diabetes mellitus
por: Kusunoki‐Tsuji, Chisato, et al.
Publicado: (2017)

Empirical antibiotic usage and bacterial superinfections in patients with COVID-19 in Japan: A nationwide survey by the Japanese Respiratory Society
por: Takazono, Takahiro, et al.
Publicado: (2022)

The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences
por: Tsuda, Yusuke, et al.
Publicado: (2018)

A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes
por: Taira, Makiko, et al.
Publicado: (2018)

Secular Trends in Dietary Intake over a 20-Year Period in People with Type 2 Diabetes in Japan: A Comparative Study of Two Nationwide Registries; Japan Diabetes Complications Study (JDCS) and Japan Diabetes Clinical Data Management Study (JDDM)
por: Takeuchi, Mizuki, et al.
Publicado: (2021)

Sodium–glucose cotransporter 2 inhibitors represent a paradigm shift in the prevention of heart failure in type 2 diabetes patients
por: Kashiwagi, Atsunori, et al.
Publicado: (2020)

Improving diagnostic accuracy of 3 Screen ICA ELISA kit in the identification of Japanese type 1 diabetes
por: Kawasaki, Eiji, et al.
Publicado: (2023)

Comparison of the clinical effect of empagliflozin on glycemic and non-glycemic parameters in Japanese patients with type 2 diabetes and cardiovascular disease treated with or without baseline metformin
por: Tanaka, Atsushi, et al.
Publicado: (2021)

Predictors for Mild and Severe Hypoglycemia in Insulin-Treated Japanese Diabetic Patients
por: Sonoda, Nao, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_49pukmjf243nlpab8h1giq0j1f